The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 09, 2017

Filed:

Oct. 08, 2014
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Washington, DC (US);

Inventors:

Thomas D. Pfister, Toronto, CA;

Allison M. Marrero, Gaithersburg, MD (US);

Ralph E. Parchment, Hagerstown, MD (US);

James H. Doroshow, Bethesda, MD (US);

Robert J. Kinders, Frederick, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); G01N 33/53 (2006.01); C07K 16/40 (2006.01); C12Q 1/48 (2006.01); G01N 33/573 (2006.01); G01N 33/68 (2006.01); C12N 5/16 (2006.01);
U.S. Cl.
CPC ...
C07K 16/40 (2013.01); C12N 5/16 (2013.01); C12Q 1/485 (2013.01); G01N 33/573 (2013.01); G01N 33/6896 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C12N 2501/06 (2013.01); C12Y 207/11001 (2013.01); G01N 2333/91205 (2013.01); G01N 2440/14 (2013.01); G01N 2500/04 (2013.01); G01N 2500/10 (2013.01); G01N 2800/2814 (2013.01); G01N 2800/52 (2013.01);
Abstract

Monoclonal antibodies that specifically bind ataxia telangiectasia-mutated and RAD3-related kinase phosphorylated at position 1989 (pT1989 ATR), antigen binding fragments, conjugates thereof, and the use of these antibodies, antigen binding fragments and conjugates are disclosed herein. Also disclosed are nucleic acids encoding these antibodies, vectors including these antibodies, and isolated host cells transformed with these nucleic acids and vectors. Methods are also disclosed for using these antibodies, such as to detect pT1989 ATR, or to determine the dose of an agent of use to treat a subject. The antibodies are also of use for identifying ATR inhibitors.


Find Patent Forward Citations

Loading…